Form 8-K - Current report:
SEC Accession No. 0001625297-25-000032
Filing Date
2025-05-08
Accepted
2025-05-08 12:21:52
Documents
15
Period of Report
2025-05-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K indv-20250508.htm   iXBRL 8-K 77778
2 EX-3.1 ex31articlesofassociation-.htm EX-3.1 763259
3 EX-99.1 ex9912025agmrnsannouncement.htm EX-99.1 58970
  Complete submission text file 0001625297-25-000032.txt   1132535

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT indv-20250508.xsd EX-101.SCH 1773
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT indv-20250508_lab.xml EX-101.LAB 22518
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT indv-20250508_pre.xml EX-101.PRE 13037
17 EXTRACTED XBRL INSTANCE DOCUMENT indv-20250508_htm.xml XML 2837
Mailing Address 234 BATH ROAD SLOUGH, BERKSHIRE X0 SL1 4EE
Business Address 234 BATH ROAD SLOUGH, BERKSHIRE X0 SL1 4EE 804-379-1090
INDIVIOR PLC (Filer) CIK: 0001625297 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37835 | Film No.: 25924916
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)